menu ☰
menu ˟

Don’t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns

16 Apr 2019
The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown. ...

Click here to view the full article which appeared in New York Times: Health

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.